Increased genetic testing required to identify concealed cardiomyopathy
Genetic testing shows that concealed cardiomyopathy is an important cause of sudden cardiac death where no cause is found from autopsy, according to researchers from the Centenary Institute, Sydney University. Dr Julia Isbister and colleagues at the institute performed genetic testing in 91 inconclusive autopsy cases where there was sudden cardiac...
Aussie data assists decision making for PCI in patients with stable IHD
Percutaneous coronary intervention (PCI) is safe and effective for symptom relief in patients with stable ischaemic heart disease (IHD) that is refractory to medical therapy, according to ‘real world’ data from an Australian registry. While revascularisation does not improve prognosis in patients with stable IHD, Victorian clinicians says its benefits in...
Is routine cardiac CT useful in suspected ACS?
Cardiac CT angiography (CCTA) in the ED does not reduce the duration or cost of an in-hospital stay in patients with a suspected ACS, research shows. A UK study randomised 250 adults presenting to the ED in 2019 with suspected ACS to standard of care plus CCTA or standard of care...
Airlines ‘leaving doctors out to dry’ after in-flight emergencies
An airline has been accused of leaving doctors “out to dry” after they render assistance during in-flight emergencies, even at the expense of a missed connection or lost seat. The issue was raised by paramedic and medical researcher Aidan Baron, who...
An airline has been accused of leaving doctors “out to dry” after they render assistance during in-flight emergencies, even at...
A matter of conscience: what to do about the national medical regulator
The national medical regulator, the Australian Health Practitioner Regulation Agency (AHPRA), is responsible for the oversight of fifteen different groups of health professionals, covering a total of 825,700 practitioners. AHPRA has become a huge and well-resourced bureaucracy which now has...
The national medical regulator, the Australian Health Practitioner Regulation Agency (AHPRA), is responsible for the oversight of fifteen different groups...
PBS listings for novel HFrEF therapy and GP prescribing of evolocumab
A novel treatment for heart failure, vericiguat, has received its first listing on the PBS from 1 December and the government has also widened PBS access to the lipid-lowering therapy PCSK9 inhibitor evolocumab. Vericiguat (Verquvo) is subsidised for use in addition...
A novel treatment for heart failure, vericiguat, has received its first listing on the PBS from 1 December and the...